NCT05906446

Brief Summary

The goal is to test feasibility of a frailty intervention, including exercises and nutritional supplementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

December 18, 2025

Status Verified

April 1, 2025

Enrollment Period

1.4 years

First QC Date

June 1, 2023

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the Intervention

    Feasibility will be determined by assessing 1) the proportion of eligible patients enrolled, and 2) the proportion of participants adherent to the intervention Range: 0-100% (higher values indicate higher feasibility).

    Estimated average <1 month

Secondary Outcomes (6)

  • Gait Speed

    Discharge (on average between 2-3 weeks)

  • Grip Strength

    Discharge (on average at 2-3 weeks)

  • The Patient Reported Outcomes Measurement Information System (PROMIS Global Health v1.2)

    Discharge (on average at 2-3 weeks)

  • Modified Barthel Index

    Discharge (on average at 2-3 weeks)

  • Adherence to exercise

    Entire study period (on average over 2-3 weeks)

  • +1 more secondary outcomes

Other Outcomes (4)

  • Length of stay

    Entire study period (on average over 2-3 weeks)

  • Hospital readmission

    Entire study period (on average over 2-3 weeks)

  • Community Discharge

    Entire study period (on average over 2-3 weeks)

  • +1 more other outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

Regular exercise sessions incorporating balance, resistance training, and walking to accommodate diminished endurance, with synergistic protein and nutritional supplementation

Other: Multicomponent (Exercise + Protein Supplementation)

Interventions

* Exercises selected from a pre-specified list, reassessed weekly * Participants will receive individualized exercise sessions, (e.g. 15-30 minutes per session, one session per day, offered five times a week) * Participants will also be offered a protein supplement within 30 min of exercise. * Sessions will be supervised

Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Community-dwelling before hospitalization
  • Age ≥ 65 years
  • Admitted to SNF directly from inpatient hospitalization
  • English speaking
  • Mild Frailty or worse, as measured by a Clinical Frailty Scale

You may not qualify if:

  • Discharged from Emergency Department
  • Non-community discharge plan on admission (e.g. plan to discharge to hospice)
  • Nothing per oral (NPO) dietary status
  • Presence of any feeding tube
  • Chronic kidney disease stage IV or worse
  • Clinician refusal
  • Inability or refusal to consume intervention products (e.g. allergies to protein supplement)
  • Inability to consent to study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hebrew Rehabilitation Center

Boston, Massachusetts, 02131, United States

Location

MeSH Terms

Conditions

Frailty

Interventions

Exercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Sandra Shi, MD MPH

    Hebrew SeniorLife

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor of Medicine

Study Record Dates

First Submitted

June 1, 2023

First Posted

June 15, 2023

Study Start

June 15, 2023

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

December 18, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations